Pharmacological treatment versus cognitive behavioral therapy in social phobia: a comparative study between moclobemide, paroxetine and cognitive behavioral therapy
Al-Azhar Medical Journal. 1999; 28 (3-4): 425-438
Dans Anglais
| IMEMR
| ID: emr-50155
ABSTRACT
Sixty-four patients with generalized social phobia were randomly assigned to Moclobemide, Paroxetine and cognitive behavior therapy groups for twelve weeks. The pattern of response was assessed. Response rate was 47.8, 50 and 23.4% for Moclobemide, Paroxetine and cognitive behavior therapy groups, respectively. Moclobemide was superior in reducing the somatic symptoms and interpersonal sensitivity. Paroxetine was superior in reducing global anxiety symptoms and obsessive compulsive symptoms. Both groups were superior to cognitive behavior therapy in reducing avoidance behavior. Cognitive behavior therapy was superior to Paroxetine in reducing interpersonal sensitivity
Recherche sur Google
Indice:
Méditerranée orientale
Sujet Principal:
Troubles phobiques
/
Thérapie comportementale
/
Résultat thérapeutique
/
Paroxétine
/
Moclobémide
Limites du sujet:
Femelle
/
Humains
/
Mâle
langue:
Anglais
Texte intégral:
Al-Azhar Med. J.
Année:
1999
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS